Park CM - Search Results

1

Allosteric Inhibition of the Tumor-Promoting Interaction Between Exon 2-Depleted Splice Variant of Aminoacyl-Transfer RNA Synthetase-Interacting Multifunctional Protein 2 and Heat Shock Protein 70.

Kim DG, Huddar S, Lim S, Kong J, Lee Y, Park CM, Lee S, Suh YG, Kim M, Lee K, Lee S, Kim S. Kim DG, et al. Among authors: park cm. J Pharmacol Exp Ther. 2021 Dec;379(3):358-371. doi: 10.1124/jpet.121.000766. Epub 2021 Sep 9. J Pharmacol Exp Ther. 2021. PMID: 34503993

2

Octahydrocyclopenta[c]pyridine and octahydrocyclopenta[c]pyran analogues as a protease activated receptor 1 (PAR1) antagonist.

Wadood A, Kim H, Park CM, Song JH, Lee S. Wadood A, et al. Among authors: park cm. Arch Pharm Res. 2015 Nov;38(11):2029-41. doi: 10.1007/s12272-015-0623-6. Epub 2015 Jun 12. Arch Pharm Res. 2015. PMID: 26068939

3

Trans-fused 5-[(tert-Butoxtycarbonyl)amino]octahydroindenes as a protease activated receptor-1 (PAR1) antagonist.

Park CM, Baek S, Kim S, Song JH, Lee S, Kim M. Park CM, et al. Arch Pharm Res. 2016 Sep;39(9):1275-95. doi: 10.1007/s12272-016-0788-7. Epub 2016 Jul 12. Arch Pharm Res. 2016. PMID: 27406140

4

Identification of Antipneumococcal Molecules Effective Against Different Streptococcus pneumoniae Serotypes Using a Resazurin-Based High-Throughput Screen.

Kim HJ, Kim N, Shum D, Huddar S, Park CM, Jang S. Kim HJ, et al. Among authors: park cm. Assay Drug Dev Technol. 2017 Jul;15(5):198-209. doi: 10.1089/adt.2017.789. Assay Drug Dev Technol. 2017. PMID: 28723269

5

Discovery of 4-hydroxy-2-oxo-1,2-dihydroquinolines as potential inhibitors of Streptococcus pneumoniae, including drug-resistant strains.

Huddar S, Park CM, Kim HJ, Jang S, Lee S. Huddar S, et al. Among authors: park cm. Bioorg Med Chem Lett. 2020 May 1;30(9):127071. doi: 10.1016/j.bmcl.2020.127071. Epub 2020 Feb 29. Bioorg Med Chem Lett. 2020. PMID: 32146051

6

Anticancer Activity of Pyrimethamine via Ubiquitin Mediated Degradation of AIMP2-DX2.

Kim DG, Park CM, Huddar S, Lim S, Kim S, Lee S. Kim DG, et al. Among authors: park cm. Molecules. 2020 Jun 15;25(12):2763. doi: 10.3390/molecules25122763. Molecules. 2020. PMID: 32549310 Free PMC article.

7

Discovery of Octahydroindenes as PAR1 Antagonists.

Lee S, Song JH, Park CM, Kim JS, Jeong JH, Cho WY, Lim DC. Lee S, et al. Among authors: park cm. ACS Med Chem Lett. 2013 Sep 10;4(11):1054-8. doi: 10.1021/ml400235c. eCollection 2013 Nov 14. ACS Med Chem Lett. 2013. PMID: 24900604 Free PMC article.

8

1-(Arylsulfonyl)-2,3-dihydro-1H-quinolin-4-one derivatives as 5-HT(6) serotonin receptor ligands.

Park CM, Choi JI, Choi JH, Kim SY, Park WK, Seong CM. Park CM, et al. Among authors: park wk. Bioorg Med Chem Lett. 2011 Jan 15;21(2):698-703. doi: 10.1016/j.bmcl.2010.12.007. Epub 2010 Dec 8. Bioorg Med Chem Lett. 2011. PMID: 21190848

9

Osthenol, a prenylated coumarin, as a monoamine oxidase A inhibitor with high selectivity.

Baek SC, Kang MG, Park JE, Lee JP, Lee H, Ryu HW, Park CM, Park D, Cho ML, Oh SR, Kim H. Baek SC, et al. Among authors: park d, park je, park cm. Bioorg Med Chem Lett. 2019 Mar 15;29(6):839-843. doi: 10.1016/j.bmcl.2019.01.016. Epub 2019 Jan 18. Bioorg Med Chem Lett. 2019. PMID: 30686752

10

Synthesis and biological evaluation of 3-acyl-2-phenylamino-1,4-dihydroquinolin-4(1H)-one derivatives as potential MERS-CoV inhibitors.

Yoon JH, Lee JY, Lee J, Shin YS, Jeon S, Kim DE, Min JS, Song JH, Kim S, Kwon S, Jin YH, Jang MS, Kim HR, Park CM. Yoon JH, et al. Among authors: park cm. Bioorg Med Chem Lett. 2019 Dec 1;29(23):126727. doi: 10.1016/j.bmcl.2019.126727. Epub 2019 Oct 9. Bioorg Med Chem Lett. 2019. PMID: 31624041 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,047 results

Search Page

Filters